---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-079672"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:03:36.484374+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aptevo receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until Dec 23, 2024

## Summary
- Received Nasdaq Staff letter on June 25, 2024, for failure to meet minimum $1.00 bid price requirement.
- Has 180 calendar days, until December 23, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If noncompliant by Dec 23, may be eligible for additional 180-day period if meets other listing standards and intends to cure via reverse stock split.
- Failure to regain compliance could result in delisting; company will monitor and evaluate options.

## SEC filing metadata
- accession: 0000950170-24-079672
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017024079672/0000950170-24-079672-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017024079672/apvo-20240625.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-079672
- JSON: https://secwatch.observer/filing/0000950170-24-079672.json
- Plain text: https://secwatch.observer/filing/0000950170-24-079672.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.